Literature DB >> 19462229

Sirt1's complex roles in neuroprotection.

Bor Luen Tang1.   

Abstract

The nicotinamide adenine dinucleotide (NAD)-activated protein deacetylase Sir2p/Sirt1 has been strongly implicated in the modulation of replicative lifespan and promotion of longevity. Part of Sirt1's capacity for lifespan extension in complex organisms may be attributed to its protective activity against neuronal degeneration. Manipulation of Sirt1's activity or levels by pharmacological and genetic means in several models of neurodegenerative diseases demonstrated its neuroprotective credentials. However, recent data have indicated that under certain contexts, Sirt1 inhibition, rather than activation, is neuroprotective. These inconsistencies highlight the complex nature of Sirt1-mediated effects. The enzyme has both histone and nonhistone targets, and could potentially act in both nuclear and cytoplasmic compartments. These activities intertwine in a manner depending on the context of a system under investigation. One needs to be cautious in extrapolating results derived from short-term observations to a longer-term context, and in assessing efficacies of Sirt1-based therapeutic approaches in treating neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19462229     DOI: 10.1007/s10571-009-9414-2

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  124 in total

1.  Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1.

Authors:  Masaya Tanno; Jun Sakamoto; Tetsuji Miura; Kazuaki Shimamoto; Yoshiyuki Horio
Journal:  J Biol Chem       Date:  2006-12-30       Impact factor: 5.157

2.  The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms.

Authors:  M Kaeberlein; M McVey; L Guarente
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

3.  Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models.

Authors:  Nilay V Patel; Marcia N Gordon; Karen E Connor; Robert A Good; Robert W Engelman; Jerimiah Mason; David G Morgan; Todd E Morgan; Caleb E Finch
Journal:  Neurobiol Aging       Date:  2004-11-25       Impact factor: 4.673

4.  Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells.

Authors:  Jin-Taek Hwang; Dae Young Kwon; Ock Jin Park; Myung Sunny Kim
Journal:  Genes Nutr       Date:  2008-02       Impact factor: 5.523

5.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

6.  Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.

Authors:  Jianfei Chao; Man-Shan Yu; Yuen-Shan Ho; Mingfu Wang; Raymond Chuen-Chung Chang
Journal:  Free Radic Biol Med       Date:  2008-07-16       Impact factor: 7.376

7.  Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington's disease.

Authors:  Judit Pallos; Laszlo Bodai; Tamas Lukacsovich; Judith M Purcell; Joan S Steffan; Leslie Michels Thompson; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2008-09-01       Impact factor: 6.150

Review 8.  The Sir2 family of protein deacetylases.

Authors:  Gil Blander; Leonard Guarente
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

9.  Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice.

Authors:  Rui-Hong Wang; Kundan Sengupta; Cuiling Li; Hyun-Seok Kim; Liu Cao; Cuiying Xiao; Sangsoo Kim; Xiaoling Xu; Yin Zheng; Beverly Chilton; Rong Jia; Zhi-Ming Zheng; Ettore Appella; Xin Wei Wang; Thomas Ried; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2008-10-07       Impact factor: 31.743

Review 10.  Resveratrol in prevention and treatment of common clinical conditions of aging.

Authors:  M Andrea Markus; Brian J Morris
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  15 in total

Review 1.  Protective effects and mechanisms of sirtuins in the nervous system.

Authors:  Feng Zhang; Suping Wang; Li Gan; Peter S Vosler; Yanqin Gao; Michael J Zigmond; Jun Chen
Journal:  Prog Neurobiol       Date:  2011-09-10       Impact factor: 11.685

Review 2.  Genetic control of necrosis - another type of programmed cell death.

Authors:  Kimberly McCall
Journal:  Curr Opin Cell Biol       Date:  2010-12       Impact factor: 8.382

3.  A dietary regimen of caloric restriction or pharmacological activation of SIRT1 to delay the onset of neurodegeneration.

Authors:  Johannes Gräff; Martin Kahn; Alireza Samiei; Jun Gao; Kristie T Ota; Damien Rei; Li-Huei Tsai
Journal:  J Neurosci       Date:  2013-05-22       Impact factor: 6.167

4.  SIRT1 Activation: A Potential Strategy for Harnessing Endogenous Protection Against Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.

Authors:  Ananth K Vellimana; Deepti Diwan; Julian Clarke; Jeffrey M Gidday; Gregory J Zipfel
Journal:  Neurosurgery       Date:  2018-09-01       Impact factor: 4.654

5.  Sirtuins: from metabolic regulation to brain aging.

Authors:  Wenzhen Duan
Journal:  Front Aging Neurosci       Date:  2013-07-23       Impact factor: 5.750

Review 6.  SIRT1 in the brain-connections with aging-associated disorders and lifespan.

Authors:  Fanny Ng; Laura Wijaya; Bor Luen Tang
Journal:  Front Cell Neurosci       Date:  2015-03-09       Impact factor: 5.505

7.  Common variants in SIRT1 and human longevity in a Chinese population.

Authors:  Rong Lin; Dongjing Yan; Yunxia Zhang; Xiaoping Liao; Gu Gong; Junjie Hu; Yunxin Fu; Wangwei Cai
Journal:  BMC Med Genet       Date:  2016-04-18       Impact factor: 2.103

Review 8.  Insulin/IGF-I and related signaling pathways regulate aging in nondividing cells: from yeast to the mammalian brain.

Authors:  Edoardo Parrella; Valter D Longo
Journal:  ScientificWorldJournal       Date:  2010-01-21

9.  When is Sirt1 activity bad for dying neurons?

Authors:  Fanny Ng; Bor L Tang
Journal:  Front Cell Neurosci       Date:  2013-10-24       Impact factor: 5.505

10.  SIRT1 mediates hypoxic preconditioning induced attenuation of neurovascular dysfunction following subarachnoid hemorrhage.

Authors:  Ananth K Vellimana; Diane J Aum; Deepti Diwan; Julian V Clarke; James W Nelson; Molly Lawrence; Byung Hee Han; Jeffrey M Gidday; Gregory J Zipfel
Journal:  Exp Neurol       Date:  2020-10-01       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.